z-logo
open-access-imgOpen Access
Trifluoperazine-Induced Suicidal Erythrocyte Death and S-Nitrosylation Inhibition, Reversed by the Nitric Oxide Donor Sodium Nitroprusside
Author(s) -
Mehrdad Ghashghaeinia,
Mauro C. Wesseling,
Elena Ramos,
Polina PetkovaKirova,
Sabrina Waibel,
Elisabeth Lang,
Rosi Bissinger,
Kossai Alzoubi,
Baerbel Edelmann,
Zohreh Hosseinzadeh,
Peter Dreischer,
Azam Shahvaroughi-Farahani,
Ulrich Mrowietz,
Martin Köberle,
Lars Kaestner,
Ingolf Bernhardt,
Antonio Martı́nez-Ruiz,
Thomas Wieder,
Florian Läng
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000479838
Subject(s) - sodium nitroprusside , nitric oxide , trifluoperazine , chemistry , pharmacology , s nitrosylation , nitrosylation , medicine , biophysics , biochemistry , biology , calmodulin , calcium , enzyme , cysteine
The high potency antipsychotic drug trifluoperazine (10-[3-(4-methyl-1-piperazinyl)-propyl]-2-(trifluoromethyl)-(10)H-phenothiazine dihydrochloride; TFP) may either counteract or promote suicidal cell death or apoptosis. Similar to apoptosis, erythrocytes may enter eryptosis, characterized by phosphatidylserine exposure at the cell surface and cell shrinkage. Eryptosis can be stimulated by an increase in cytoplasmic Ca2+ concentration ([Ca2+]i) and inhibited by nitric oxide (NO). We explored whether TFP treatment of erythrocytes induces phosphatidylserine exposure, cell shrinkage, and calcium influx, whether it impairs S-nitrosylation and whether these effects are inhibited by NO.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom